Rendimiento predictivo de Advanced-DiaRem para la remisión de la diabetes después de la cirugía de bypass gástrico

Video Experimental Relacionado

Updated: Jun 13, 2026

Roux-en-Y Gastric Bypass Operation in Rats
07:37

Roux-en-Y Gastric Bypass Operation in Rats

Published on: June 11, 2012

24.2K

Arash Abdollahi1, Maziar Afshar2, Yeganeh Karimi3

  • 1Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Islamic Republic of Iran.

Obesity surgery
|January 3, 2026
PubMed
Resumen

No abstract available in PubMed .

Palabras clave:
Avanzado - DiaRemDesempeño diagnósticoCirugía bariátrica metabólicaCirugía de derivación gástrica de Roux-en-Y

Más Videos Relacionados

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.6K
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

5.9K

Videos de Conceptos Relacionados

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...